Literature DB >> 355724

Mesangial proliferative glomerulonephritis.

H K Bhasin, J G Abuelo, R Nayak, A R Esparza.   

Abstract

Eleven cases of mesangial proliferative glomerulonephritis whose kidney biopsies were studied with light, immunofluorescent, and electron microscopy are described. Nine patients presented with nephrotic syndrome, one with proteinuria and hematuria, and one with proteinuria alone. Morphologically mesangial proliferative glomerulonephritis was characterized by diffuse mesangial cell proliferation and some increase in mesangial matrix. On immunofluorescence, mesangial IgM deposition was observed in all cases and was considered a distinct feature of mesangial proliferative glomerulonephritis. Electron microscopy showed electron-dense granular deposits within the mesangial matrix in four cases. The clinical course was variable. Of the eight cases with nephrotic syndrome, four treated with steroids alone and four treated with steroids and cytotoxic drugs, one in each group achieved remission while the remaining patients continued to have steroid dependency or resistance. Two of these latter patients manifested steroid responsiveness, steroid resistance, and spontaneous remission at different times in their courses. Renal function remained normal in all. These cases demonstrate that mesangial proliferative glomerulonephritis is an entity characterized by increased mesangial cellularity, deposition of IgM in a mesangial distribution, a relatively benign course, and variable response to treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355724

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  26 in total

1.  Comment on: IgM nephropathy: Can we still ignore it.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2013-10-01

2.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

3.  IgM associated primary diffuse mesangial proliferative glomerulonephritis.

Authors:  W Lawler; G Williams; P Tarpey; N P Mallick
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

4.  Minimal change nephrotic syndrome. Histopathology and steroid-responsiveness.

Authors:  J Bernstein; C M Edelmann
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

5.  Nephrotic syndrome in Saudi children clinicopathological study of 150 cases.

Authors:  T K Mattoo; M A Mahmood; M S al-Harbi
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

6.  Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?

Authors:  Mateja Vintar Spreitzer; Alenka Vizjak; Dušan Ferluga; Rajko B Kenda; Tanja Kersnik Levart
Journal:  Pediatr Nephrol       Date:  2013-07-13       Impact factor: 3.714

7.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

8.  Fatal Pneumocystis pneumonia in a child treated for focal segmental glomerulosclerosis.

Authors:  J L Murphy; H L Kano; P J Chenaille; S P Makker
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  IGA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions.

Authors:  G Syré
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

10.  Mesangial alterations in steroid-responsive minimal change nephrotic syndrome.

Authors:  J Fydryk; R Waldherr; G Mall; K Schärer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.